دورية أكاديمية
أعرض في EDS

Whole Yeast Vaccine Displaying ZIKV B and T Cell Epitopes Induces Cellular Immune Responses in the Murine Model.

التفاصيل البيبلوغرافية
العنوان: Whole Yeast Vaccine Displaying ZIKV B and T Cell Epitopes Induces Cellular Immune Responses in the Murine Model.
المؤلفون: Silva AJD; Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil., de Jesus ALS; Federal Institute of Mato Grosso, Lucas do Rio Verde 78455-000, Brazil., Leal LRS; Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil., de Macêdo LS; Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil., da Silva Barros BR; Department of Antibiotics, Federal University of Pernambuco, Recife 50670-901, Brazil., de Sousa GF; Department of Antibiotics, Federal University of Pernambuco, Recife 50670-901, Brazil., da Paz Leôncio Alves S; Department of Pharmacy, Federal University of Pernambuco, Recife 50670-901, Brazil., Pena LJ; Department of Virology and Experimental Therapy, Instituto Aggeu Magalhães, Oswaldo Cruz Foundation, Recife 50670-901, Brazil., de Melo CML; Department of Antibiotics, Federal University of Pernambuco, Recife 50670-901, Brazil., de Freitas AC; Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, Brazil.
المصدر: Pharmaceutics [Pharmaceutics] 2023 Jul 06; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 06.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Improving antigen presentation is crucial for the success of immunization strategies. Yeasts are classically used as biofactories to produce recombinant proteins and are efficient vehicles for antigen delivery, in addition to their adjuvant properties. Despite the absence of epidemic outbreaks, several vaccine approaches continue to be developed for Zika virus infection. The development of these prophylactic strategies is fundamental given the severity of clinical manifestations, mainly due to viral neurotropism. The present study aimed to evaluate in vivo the immune response induced by P. pastoris recombinant strains displaying epitopes of the envelope (ENV) and NS1 ZIKV proteins. Intramuscular immunization with heat-attenuated yeast enhanced the secretion of IL-6, TNF-α, and IFN-γ, in addition to the activation of CD4 + and CD8 + T cells, in BALB/c mice. P. pastoris displaying ENV epitopes induced a more robust immune response, increasing immunoglobulin production, especially IgG isotypes. Both proposed vaccines showed the potential to induce immune responses without adverse effects, confirming the safety of administering P. pastoris as a vaccine vehicle. Here, we demonstrated, for the first time, the evaluation of a vaccine against ZIKV based on a multiepitope construct using yeast as a delivery system and reinforcing the applicability of P. pastoris as a whole-cell vaccine.
References: Med Microbiol Immunol. 2016 Jun;205(3):269-73. (PMID: 26702627)
J Virol Methods. 2019 May;267:8-15. (PMID: 30779938)
Int J Med Sci. 2011 Mar 18;8(3):239-44. (PMID: 21448311)
J Immunol Res. 2016;2016:4131324. (PMID: 28078309)
J Infect Dis. 2017 Dec 16;216(suppl_10):S957-S963. (PMID: 29267918)
Vaccine. 2011 Oct 19;29(45):8165-73. (PMID: 21856351)
Vaccines (Basel). 2018 Jul 21;6(3):. (PMID: 30037078)
Vaccine. 2009 Dec 10;28(1):187-94. (PMID: 19789093)
PLoS Pathog. 2017 Feb 23;13(2):e1006184. (PMID: 28231312)
FEMS Yeast Res. 2010 Dec;10(8):1060-9. (PMID: 20707820)
Cells. 2021 May 26;10(6):. (PMID: 34073501)
Biotechnol Prog. 2010 Mar-Apr;26(2):542-7. (PMID: 19950135)
FEMS Yeast Res. 2019 Mar 1;19(2):. (PMID: 30668686)
PLoS Pathog. 2019 Jan 24;15(1):e1007474. (PMID: 30677097)
Vaccines (Basel). 2018 Oct 18;6(4):. (PMID: 30340377)
Biotechnol Lett. 2011 Jan;33(1):1-9. (PMID: 20872167)
Animal Model Exp Med. 2020 Dec 18;3(4):304-315. (PMID: 33532705)
Virol Sin. 2018 Jun;33(3):213-226. (PMID: 29774519)
J Clin Lab Anal. 2020 Jan;34(1):e23024. (PMID: 31471934)
Front Immunol. 2014 Oct 20;5:520. (PMID: 25368619)
Curr Opin Biotechnol. 2013 Dec;24(6):1094-101. (PMID: 23522654)
Am J Public Health. 2017 Jun;107(6):960-965. (PMID: 28426311)
Med Microbiol Immunol. 2019 Dec;208(6):703-714. (PMID: 30879197)
Vaccines (Basel). 2021 Sep 09;9(9):. (PMID: 34579241)
N Engl J Med. 2019 Oct 10;381(15):1444-1457. (PMID: 31597021)
Biosci Biotechnol Biochem. 2010;74(7):1362-7. (PMID: 20622458)
Vaccine. 2021 Apr 28;39(18):2545-2554. (PMID: 33814233)
J Virol. 2017 Oct 27;91(22):. (PMID: 28835502)
Vaccine. 2019 Sep 3;37(37):5578-5587. (PMID: 31399274)
PLoS One. 2014 Jan 27;9(1):e86658. (PMID: 24475165)
Cytokine Growth Factor Rev. 2010 Dec;21(6):413-23. (PMID: 21074482)
Bioengineering (Basel). 2021 Aug 31;8(9):. (PMID: 34562941)
Nat Commun. 2018 Aug 7;9(1):3136. (PMID: 30087337)
PLoS Pathog. 2018 Sep 13;14(9):e1007237. (PMID: 30212537)
PLoS Negl Trop Dis. 2019 Oct 7;13(10):e0007763. (PMID: 31589611)
Vaccine. 2014 Apr 1;32(16):1869-76. (PMID: 24530147)
Front Immunol. 2021 Mar 04;12:632714. (PMID: 33746970)
PLoS One. 2015 Jun 17;10(6):e0128764. (PMID: 26083446)
FEMS Yeast Res. 2022 May 23;22(1):. (PMID: 35488874)
Yeast. 2005 Jul 15;22(9):725-37. (PMID: 16034819)
Nat Commun. 2019 Aug 27;10(1):3859. (PMID: 31455769)
FEMS Yeast Res. 2015 Feb;15(1):1-16. (PMID: 25130199)
Blood. 2017 Apr 6;129(14):1991-2001. (PMID: 28143882)
Trends Immunol. 2017 Aug;38(8):594-605. (PMID: 28579320)
Sci Rep. 2022 Jan 7;12(1):53. (PMID: 34997041)
Laboratorio. 1958 Dec;26(156):511-7. (PMID: 13655586)
Anal Sci. 2009 Jan;25(1):41-9. (PMID: 19139571)
Nat Med. 2001 May;7(5):625-9. (PMID: 11329066)
Sci Adv. 2019 Dec 11;5(12):eaax2388. (PMID: 31844662)
PLoS One. 2014 Jul 22;9(7):e101904. (PMID: 25051027)
معلومات مُعتمدة: 88887.507421/ 2020-00 National Council for Scientific and Technological Development; 440315/2022-0 National Council for Scientific and Technological Development; APQ-1482-2.02/22 Foundation for the Support of Science and Technology of Pernambuco
فهرسة مساهمة: Keywords: P. pastoris; multi-epitope; yeast surface display; yeast-based vaccines
تواريخ الأحداث: Date Created: 20230729 Latest Revision: 20230801
رمز التحديث: 20230801
مُعرف محوري في PubMed: PMC10385271
DOI: 10.3390/pharmaceutics15071898
PMID: 37514084
قاعدة البيانات: MEDLINE
الوصف
تدمد:1999-4923
DOI:10.3390/pharmaceutics15071898